Business news

    Rhythm Biosciences (ASX:RHY) retains ISO certification for sixth year

    Article Image

    Rhythm Biosciences maintained its ISO 13485:2016 certification for its quality management system for the sixth consecutive year.

    The certification supports global commercialisation efforts and regulatory approvals, enhancing confidence among partners and in the market.

    Donald Joseph, Rhythm Biosciences' quality manager, noted the importance of this achievement for future endeavours, particularly the international launch of ColoSTAT.

    Disclaimer

    Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relates to your unique circumstances. Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of, or reliance on the information provided directly or indirectly by use of this platform.

    Publisher
    Grafa